sodium hydroxide has been researched along with sirolimus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, HS; Kim, JC; Kwon, YS; Shin, JS; Son, Y | 1 |
| Chung, TY; Hyon, JY; Koh, JW; Shin, YJ; Wee, WR; Yi, K | 1 |
| Arefian, E; Atyabi, F; Dinarvand, R; Heydari, M; Khonsari, F; Mahbod, M; Shahhosseini, S; Soleimani, M; Zahir-Jouzdani, F | 1 |
| Chen, L; Du, S; Gao, L; Han, J; Li, J; Niu, Z; Shi, Y; Tian, H; Wei, L; Yang, P | 1 |
4 other study(ies) available for sodium hydroxide and sirolimus
| Article | Year |
|---|---|
Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
Topics: Animals; Apoptosis; Carrier Proteins; Cell Movement; Cell Proliferation; Corneal Neovascularization; Cytokines; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Growth Substances; Immunosuppressive Agents; In Situ Nick-End Labeling; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sirolimus; Sodium Hydroxide; TOR Serine-Threonine Kinases; Umbilical Veins | 2005 |
Combined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cells - chemically injured keratocyte reaction.
Topics: Acetylcysteine; Antioxidants; Burns, Chemical; Cells, Cultured; Coculture Techniques; Cornea; Corneal Injuries; Corneal Keratocytes; Dexamethasone; Drug Combinations; Humans; Immunosuppressive Agents; Interleukin-6; Intramolecular Oxidoreductases; Leukocytes, Mononuclear; Macrophage Migration-Inhibitory Factors; Matrix Metalloproteinase 9; Mycophenolic Acid; Sirolimus; Sodium Hydroxide; Thioctic Acid; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2011 |
Nanostructured lipid carriers containing rapamycin for prevention of corneal fibroblasts proliferation and haze propagation after burn injuries: In vitro and in vivo.
Topics: Administration, Ophthalmic; Animals; Burns, Chemical; Cell Proliferation; Cells, Cultured; Cornea; Corneal Injuries; Corneal Neovascularization; Corneal Opacity; Disease Models, Animal; Drug Carriers; Drug Compounding; Eye Burns; Fibroblasts; Fibrosis; Humans; Lipids; Male; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Sirolimus; Sodium Hydroxide; Wound Healing | 2019 |
Rapamycin ameliorates corneal injury after alkali burn through methylation modification in mouse TSC1 and mTOR genes.
Topics: Actins; Animals; Blotting, Western; Burns, Chemical; Chromones; Corneal Injuries; Disease Models, Animal; DNA Methylation; Eye Burns; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Immunosuppressive Agents; Male; Mice; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Sirolimus; Sodium Hydroxide; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Vascular Endothelial Growth Factor A | 2021 |